I'm expecting that analysts who report on NEO will report before the next conference call. NEO has already guided better then analyst forecast for 2015. $6 is a real possibility before the conference call, but that call will need to have positive earning surprises to maintain that price into next year where double digit earnings are expected.
Recent NEO News
- NeoGenomics to Present New Research at ASCO Annual Meeting 2026 • Business Wire • 05/26/2026 11:05:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 08:19:44 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:05:31 PM
- NeoGenomics to Participate in Upcoming Investor Conferences • Business Wire • 05/15/2026 01:05:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/13/2026 09:30:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:19:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:18:56 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/07/2026 08:34:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:27:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2026 08:27:19 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 03:41:23 PM
- NeoGenomics Shares Jump on Earnings and Analyst Upgrades • IH Market News • 04/29/2026 11:27:26 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/28/2026 09:01:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:59:44 PM
- NeoGenomics Reports First Quarter 2026 Results • Business Wire • 04/28/2026 08:05:00 PM
- NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration • Business Wire • 04/23/2026 11:05:00 AM
- NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 • Business Wire • 04/13/2026 11:05:00 AM
- NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 • Business Wire • 04/07/2026 11:05:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/06/2026 08:26:16 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/06/2026 08:25:01 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/06/2026 08:22:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:39:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:38:47 PM
- NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling • Business Wire • 03/16/2026 11:05:00 AM
